dr. tyna moore glp-1 I was joined by and Calley Means on The Doctor Hyman Show, where we explored both sides of using GLP-1s. We challenge the notion of treating obesity, discuss its benefits, and how our Dr Tyna Moore on the

Analysis of data from prior diabetes trials reveals that these agents seem up to the task

The images used for the graphical abstract and in Figures 3A and 4B were created using BioRender.com

10.1016/j.lfs.2022.121141 28 VillalbaA.Rodriguez-FernandezS.Perna-BarrullD.AmpudiaR

Emerging research suggests that GLP-1 medications may help reduce addictive behaviors, including alcohol cravings and cigarette smoking

95% CI, 1.06 to 1.21) compared to SGLT-2 inhibitor therapy with insulin [93]

In recent years, social media platforms have been used to study: Chronic diseases Mental health trends Vaccine reactions Medication side effects The recent GLP-1 study demonstrates how artificial intelligence can analyze vast amounts of patient-generated content and identify patterns that might otherwise go unnoticed